← Every company

Who Owns Anika Therapeutics Inc

Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Anika Therapeutics Inc.

Who crossed 5% of ANIK →
Managers holding
3
as of 2026-09-30
Reported value
$14.7K
summed across filings
Shares held
749
Added vs trimmed
1 / 1
since each filer's last quarter

Positions as of 2026-09-30

Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.

ManagerValue
GAMMA Investing LLCCommon Stock381 shadded$7.5K
Farther Finance Advisors, LLCStock209 shtrimmed$4.1K
MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock159 shheld$3.1K

Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.

More on ANIK

Follow Anika Therapeutics Inc (ANIK) by email

New trades in Anika Therapeutics Inc (ANIK) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets